BridgeMD
New treatment option for Heavy Drinking
Official title Affirmative Psychotherapy for Sexual Minority Women's Mental and Behavioral Health
ClinicalTrials.gov ID: NCT05509166
What this study is testing
- What it's testing
- The purpose of this 2-arm randomized controlled trial is to assess the efficacy of a 10-session lesbian, gay, bisexual, transgender, and queer (LGBTQ)-affirmative cognitive-behavioral psychotherapy (CBT) delivered via telehealth in a large sample of sexual minority women (SMW) in New York, New Jersey and Pennsylvania. The investigators will assess whether the EQuIP (Empowering Queer Identities in Psychotherapy) treatment demonstrates significant reductions in heavy drinking (HD) and mental health symptoms (e.g., depression) compared to LGBTQ-affirmative treatment-as-usual.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- be 18 years of age or older
- be fluent in English
- self-identify as lesbian, bisexual, queer, pansexual, or other non-heterosexual identity 3) report at ≥ 8 standard drinks/week, on average, in the...
You likely can't join if
- report current mental health treatment ≥1 day/mo
- report having received any CBT in the past 3 months
- report current alcohol or drug abuse treatment, except mutual self-help (e.g., Alcoholics Anonymous)
- need alcohol detoxification indicated by ≥9 on Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar)
- exhibit active psychosis or active mania, as assessed by the Structured Clinical Interviews for DSM-5 Disorders (SCID) Psych Screen
- exhibit active suicidality or active homicidality, as assessed by the SCID-Psych Screen
See the full eligibility criteria
- be 18 years of age or older
- be fluent in English
- self-identify as lesbian, bisexual, queer, pansexual, or other non-heterosexual identity 3) report at ≥ 8 standard drinks/week, on average, in the past 30 days, OR report at least 2 heavy drinking days ( ≥ 4 drinks in...
- report current mental health treatment ≥1 day/mo
- report having received any CBT in the past 3 months
- report current alcohol or drug abuse treatment, except mutual self-help (e.g., Alcoholics Anonymous)
- need alcohol detoxification indicated by ≥9 on Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar)
- exhibit active psychosis or active mania, as assessed by the Structured Clinical Interviews for DSM-5 Disorders (SCID) Psych Screen
- exhibit active suicidality or active homicidality, as assessed by the SCID-Psych Screen
- be currently legally mandated to attend treatment
- demonstrate gross cognitive impairment, as assessed with the Telephone Interview for Cognitive Status
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.